Literature DB >> 12646606

IL-9 enhances the growth of human mast cell progenitors under stimulation with stem cell factor.

Shigeyuki Matsuzawa1, Kazuo Sakashita, Tatsuya Kinoshita, Susumu Ito, Tetsuji Yamashita, Kenichi Koike.   

Abstract

We examined the effects of IL-9 on human mast cell development from CD34(+) cord blood (CB) and peripheral blood cells in serum-deprived cultures. IL-9 apparently enhanced cell production under stimulation with stem cell factor (SCF) from CD34(+) CB cells. A great majority of the cultured cells grown with SCF + IL-9 became positive for tryptase at 4 wk. In methylcellulose cultures of CD34(+) CB cells, IL-9 increased both the number and size of mast cell colonies grown with SCF. Furthermore, SCF + IL-9 caused an exclusive expansion of mast cell colony-forming cells in a 2-wk liquid culture of CD34(+) CB cells, at a level markedly greater than for SCF alone. Clonal cell cultures and RT-PCR analysis showed that the targets of SCF + IL-9 were the CD34(+)CD38(+) CB cells rather than the CD34(+)CD38(-) CB cells. IL-9 neither augmented the SCF-dependent generation of progeny nor supported the survival of 6-wk-cultured mast cells. Moreover, there was no difference in the appearance of tryptase(+) cells and histamine content in the cultured cells between SCF and SCF + IL-9. The addition of IL-9 increased numbers of mast cell colonies grown with SCF from CD34(+) peripheral blood cells in children with or without asthma. It is of interest that mast cell progenitors of asthmatic patients responded to SCF + IL-9 to a greater extent than those of normal controls. Taken together, IL-9 appears to act as a potent enhancer for the SCF-dependent growth of mast cell progenitors in humans, particularly asthmatic patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12646606     DOI: 10.4049/jimmunol.170.7.3461

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  40 in total

Review 1.  Janus kinase-3 dependent inflammatory responses in allergic asthma.

Authors:  Rama Malaviya; Debra L Laskin; Ravi Malaviya
Journal:  Int Immunopharmacol       Date:  2010-04-27       Impact factor: 4.932

Review 2.  Molecular regulation of mast cell development and maturation.

Authors:  Chenxiong Liu; Zhigang Liu; Zhilong Li; Yaojiong Wu
Journal:  Mol Biol Rep       Date:  2009-07-31       Impact factor: 2.316

Review 3.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

Review 4.  The symphony of the ninth: the development and function of Th9 cells.

Authors:  Rukhsana Jabeen; Mark H Kaplan
Journal:  Curr Opin Immunol       Date:  2012-02-22       Impact factor: 7.486

Review 5.  Regulatory roles of mast cells in immune responses.

Authors:  Hideaki Morita; Hirohisa Saito; Kenji Matsumoto; Susumu Nakae
Journal:  Semin Immunopathol       Date:  2016-05-06       Impact factor: 9.623

Review 6.  Th9 and other IL-9-producing cells in allergic asthma.

Authors:  Sonja Koch; Nina Sopel; Susetta Finotto
Journal:  Semin Immunopathol       Date:  2016-11-17       Impact factor: 9.623

7.  TH9 cells are required for tissue mast cell accumulation during allergic inflammation.

Authors:  Sarita Sehra; Weiguo Yao; Evelyn T Nguyen; Nicole L Glosson-Byers; Nahid Akhtar; Baohua Zhou; Mark H Kaplan
Journal:  J Allergy Clin Immunol       Date:  2015-03-05       Impact factor: 10.793

Review 8.  Mast cells as sources of cytokines, chemokines, and growth factors.

Authors:  Kaori Mukai; Mindy Tsai; Hirohisa Saito; Stephen J Galli
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 9.  Immunity to gastrointestinal nematode infections.

Authors:  D Sorobetea; M Svensson-Frej; R Grencis
Journal:  Mucosal Immunol       Date:  2018-01-03       Impact factor: 7.313

Review 10.  A brief history of IL-9.

Authors:  Ritobrata Goswami; Mark H Kaplan
Journal:  J Immunol       Date:  2011-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.